Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA

NCT00440804 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Patent Ductus Arteriosus

Interventions

DRUG: ibuprofen l-lysine iv solution (NeoProfen (R) )

Sponsor

Farmacon